NEWS
Real estate
CIM and Envivo join forces to take over Heathcotes Group Civitas Investment Management (CIM), an impact investor specialising in government-backed community real estate assets, has acquired care provider Heathcotes for an undisclosed price. The transaction was undertaken in partnership with Envivo Group, a care provider in the UK residential care and supported living sectors. As part of the transaction, CIM has acquired all the healthcare real estate assets of Heathcotes on behalf of underlying investment clients and Envivo Group has purchased the operational care business. Founded in 2005, Heathcotes has 72 UK healthcare facilities providing specialist residential accommodation for adults and children with learning disabilities, mental health and associated
complex needs. It works with more than 50 local authorities and clinical commissioning groups. CIM group director Tom Pridmore said: “We are delighted to have partnered with Envivo Group to announce this significant transaction, one of the largest in UK healthcare this year. The healthcare sector in which we invest is continuing to demonstrate strongly its resilience, with a service offer that is uncorrelated to the broader economy, that delivers positive social outcomes, reliable economic returns and clear value for money for the public purse. We believe that the combination of skills that we have brought together will enable Heathcotes to continue to grow successfully to meet the demand for its services whilst continuing
to place the needs of the service users and staff at the heart of its activities.” Paul Marriner, chairman of Envivo Group added: “We are delighted to have partnered with Civitas and acquired the Heathcotes Group. Heathcotes is a well-respected, highquality care provider, and we are looking forward to working with their management team to invest in systems and infrastructure to further enhance their quality, that enables them to achieve excellent outcomes for people that the group supports, as part of the wider Envivo family.” Brenda n Kelly, ma nag i ng director of Heathcotes, said: “I really welcome this new chapter in the development of Heathcotes. Envivo’s core values and focus on the best outcomes for the
Brendan Kelly, managing director of Heathcotes individuals we support, their families and our colleagues, is closely aligned with Heathcotes’ values. As we transition to new ownership, we are all looking forward to working together with the wider Envivo family over the coming months and years ahead.” Civitas was advised on commercial due diligence by Connell Consulting.
Medical technology
HealthHero acquires digital triage provider Doctorlink
Electronic health data start-up uMed raises £3.7m
Digital health company HealthHero has acquired digital triage provider Doctorlink after global investor Eight Roads Ventures sold its stake. Doctorlink provides care for more than 12.5 million patients in the UK across more than 1,500 GP surgeries in the NHS. London-based HealthHero operates in the UK, Ireland and Germany, providing holistic digital healthcare services. The acquisition of Doctorlink adds online triage and health risk assessment to its services. Ranjan Singh, co-founder and chief executive of HealthHero said: “This marks an exciting step for both Doctorlink and HealthHero. By working together, we aim to create
Healthtech start-up uMed has raised £3.7 million from investors AlbionVC, Delin Ventures and Playfair Capital, as well as Silicon Valley’s 11.2 Capital. London-based uMed’s platform automates the clinical study process, creating patient registries that combine electronic health data with data from each patient which can include genomic and biomarker samples. This automation allows all healthcare providers, from GP practices to hospitals, to participate in multiple research programmes simultaneously. uMed founder Dr Matt Wilson sa id: “O u r tec h nolog y ca n support healthcare providers in finding appropriate patients to
12
the gold-standard in digital primary healthcare services by combining Doctorlink’s industry-leading tech tools with our existing platform and best-in-breed clinical operations.” Rupert Spiegelberg, chief executive of Doctorlink, added: “I am delighted that Doctorlink will be able to take the next step of its journey within the HealthHero family of companies enabling it to offer a broader and deeper set of services to its customers and invest more in its world-beating technology platform. “I have enjoyed every minute of what has been an incredible year for the company and believe we have found the right strategic fit for the business.”
participate in medical research, including large-scale patient registries which usually demands laborious, manual processes on top of their already complex and heavy workloads. “As our technology is uniquely able to reach back compliantly from the electronic health record to the patients, the process for building research registries can be heavily automated. It means clinicians can focus on patient care, while patients are given the opportunity to participate in many more studies from home, with full transparency over use of their health records.” In October last year, uMed secured almost £1 million in seed investment from Playfair Capital.
HealthInvestor UK • December 2020
